Biogen said it held its 2025 Annual Meeting of Stockholders on June 17, 2025, where stockholders elected 11 director nominees to serve one-year terms until the 2026 annual meeting of stockholders, or until their successors are duly elected and qualified.

1. 01

   Biogen said it held its 2025 Annual Meeting of Stockholders on June 17, 2025, where stockholders elected 11 director nominees to serve one-year terms until the 2026 annual meeting of stockholders, or until their successors are duly elected and qualified.

2. 02

   The company disclosed that Monish Patolawala received the most votes for, with 115,162,666 votes in favor, while Caroline D. Dorsa received 90,200,723 votes for and 25,487,099 votes against.

3. 03

   Biogen said stockholders ratified PricewaterhouseCoopers LLP as the company's independent outside auditor for the fiscal year ending December 31, 2025, with 120,065,433 votes for, 5,916,416 against and 234,188 abstentions.

4. 04

   The company disclosed that stockholders approved the advisory vote on executive compensation, with 78,531,756 votes for, 37,113,368 against, 364,062 abstentions and 10,206,851 broker non-votes.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.